1. |
湯釗猷. 關于肝癌治療的策略 [J]. 臨床肝膽病雜志, 2011,27(4):337-339.
|
2. |
Cedrone A, Rapaccini GL, Pompili M, et al. Portal vein thrombosis complicating hepatocellular carcinoma. Value of ultrasoundguided fine-needle biopsy of the thrombus in the therapeutic management [J]. Liver, 1996, 16(2): 94-98.
|
3. |
Llovet JM, Bustamante J, Castells A, et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials [J]. Hepatology,1999, 29(1): 62-67.
|
4. |
周儉, 樊嘉, 肖永勝.肝細胞癌門靜脈癌栓形成機制 [J]. 實用腫瘤雜志, 2009, 24(5):425-428..
|
5. |
Wang T, Hu HS, Feng YX, et al. Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma [J]. Br J Cancer,2010, 102(11): 1618-1626.
|
6. |
Li N, Guo W, Shi J, et al. Expression of the chemokine receptor CXCR4 in human hepatocellular carcinoma and its role in portal vein tumor thrombus [J]. J Exp Clin Cancer Res, 2010, 29:156.
|
7. |
Guo W, Xue J, Shi J, et al. Proteomics analysis of distinct portal vein tumor thrombi in hepatocellular carcinoma patients [J]. J Proteome Res, 2010, 9(8): 4170-4175.
|
8. |
Liu S, Guo W, Shi J, et al. MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma [J]. J Hepatol, 2012, 56(2):389-396.
|
9. |
孫保木, 羅明, 吳孟超. 門靜脈癌栓及其治療 [J]. 肝臟,2009, 14(1):56-58.
|
10. |
程樹群, 吳孟超, 陳漢, 等. 癌栓分型對肝細胞性肝癌合并門靜脈癌栓治療及預后的指導意義 [J]. 中華醫學雜志, 2004,84(1):3-5.
|
11. |
Shi J, Lai EC, Li N, et al. A new classification for hepatocellular carcinoma with portal vein tumor thrombus [J]. J Hepatobiliary Pancreat Sci, 2011, 18(1): 74-80.
|
12. |
Fan J, Wu ZQ, Zhou J, et al. Hepatocellular carcinoma associated with tumor thrombosis in the portal vein: the effects of different treatments [J]. Hepatobiliary Pancreat Dis Int, 2003, 2(4):513-519.
|
13. |
Yamaoka Y, Kumada K, Ino K, et al. Liver resection for hepatocellular carcinoma (HCC) with direct removal of tumor thrombi in the main portal vein [J]. World J Surg, 1992, 16(6): 1172-1176.
|
14. |
余業勤, 徐東波, 鄭亞新, 等. 肝癌切除聯合門靜脈癌栓取出術治療肝癌——附25 例報道 [J]. 中國實用外科雜志, 1994,14(1):18-19.
|
15. |
王曉穎, 樊嘉. 肝癌合并門靜脈癌栓的治療方法及價值 [J].肝膽外科雜志, 2009, 17(1):9-11.
|
16. |
樊嘉, 王征. 肝癌外科治療的進展 [J]. 實用醫院臨床雜志,2011, 8(1):16-19.
|
17. |
陳榮新, 葉勝龍, 樊嘉, 等. 肝動脈化療栓塞對原發性肝癌伴門靜脈癌栓的治療作用 [J]. 中華腫瘤防治雜志, 2006, 13(7):530-531.
|
18. |
羅劍鈞, 顏志平, 王建華, 等. 腔內植入125I 粒子條及支架聯合經動脈化療栓塞治療原發性肝癌合并門脈主干癌栓的療效 [J]. 中華腫瘤雜志, 2011, 33(7):535-539.
|
19. |
Yoshidome H, Takeuchi D, Kimura F, et al. Treatment strategy for hepatocellular carcinoma with major portal vein or inferior vena cava invasion: a single institution experience [J]. J Am Coll Surg, 2011, 212(5): 796-803.
|
20. |
Yamamoto K, Masuzawa M, Kato M, et al. Evaluation of combined therapy with chemoembolization and ethanol injection for advanced hepatocellular carcinoma [J]. Semin Oncol, 1997,24(2 Suppl 6): S6-50-S6-55.
|
21. |
陸正華, 沈鋒, 楊家和, 等. 經皮激光消融治療肝癌門靜脈癌栓 [J]. 中國微創外科雜志, 2007, 7(4):331-333.
|
22. |
吳丹西, 解素娟, 陳德發, 等. 高強度超聲聚焦刀治療門靜脈癌栓的臨床觀察 [J]. 中國現代藥物應用, 2009, 3(13):25-27.
|
23. |
Zeng ZC, Fan J, Tang ZY, et al. A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus [J]. Int J Radiat Oncol Biol Phys, 2005, 61(2): 432-443.
|
24. |
Yoon SM, Lim YS, Won HJ, et al. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes [J]. Int J Radiat Oncol Biol Phys, 2011 May 26, [ Epub ahead of print].
|
25. |
Zhang FJ, Li CX, Jiao DC, et al. CT guided 125iodine seed implantation for portal vein tumor thrombus in primary hepatocellular carcinoma [J]. Chin Med J (Engl), 2008, 121(23): 2410-2414.
|
26. |
Tsai AL, Burke CT, Kennedy AS, et al. Use of yttrium-90 microspheres in patients with advanced hepatocellular carcinoma and portal vein thrombosis [J]. J Vasc Interv Radiol, 2010, 21(9):1377-1384.
|
27. |
錢軍, 秦叔逵. 原發性肝癌并發門靜脈癌栓的治療策略 [J].腫瘤研究與臨床, 2010, 22(2):76-79.
|
28. |
Kasai K, Ushio A, Kasai Y, et al. Therapeutic efficacy of combination therapy with intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma with portal venous invasion [J]. Cancer, 2011 Nov 9. doi:10.1002/cncr. 26648.[ Epub ahead of print].
|
29. |
湯釗猷. 中西醫結合治療肝癌的思考 [J]. 臨床肝膽病雜志,2011, 27(5):449-450.
|